EMCURE:NSE
Emcure Pharmaceuticals Ltd
₹2,339.00
arrow_downward
-0.24%(-5.70) 1D
Nob 20, 3:30:03 PM GMT+5:30 · INR
search
Lahat ng simbolo
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa EMCURE...
Buksan
₹2,357.90
Mataas
₹2,389.00
Mababa
₹2,331.00
Mkt. cap
443.73B
Avg. na dami
229.10K
Dami
79.03K
Dividend
0.15%
Bawat tatlong buwang dividend
₹0.90
Petsa ng ex-dividend
Set 4, 2026
P/E ratio
49.10
Mataas nang 52-wk
₹2,429.90
Mababa nang 52-wk
₹1,312.30
EPS
₹47.64
Bilang ng mga empleyado
7K
Buksan
₹2,357.90
Mataas
₹2,389.00
Mababa
₹2,331.00
Mkt. cap
443.73B
Avg. na dami
229.10K
Dami
79.03K
Dividend
0.15%
Bawat tatlong buwang dividend
₹0.90
Petsa ng ex-dividend
Set 4, 2026
P/E ratio
49.10
Mataas nang 52-wk
₹2,429.90
Mababa nang 52-wk
₹1,312.30
EPS
₹47.64
Bilang ng mga empleyado
7K
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
FOREX.com
·
2 oras ang nakalipas
S&P 500, Nasdaq 100 Drive into Correction Territory
TradingView
·
4 oras ang nakalipas
Ed Yardeni Says Investors Are Overreacting to S&P 500 Selloff
TradingKey
·
7 oras ang nakalipas
S&P 500 Falls Below 200-Day Moving Average: Buy-the-Dip Opportunity or Bear Market Warning?
cwibc.co.id
·
2 oras ang nakalipas
Wall Street Sell-Off Pushes S&P 500 and Dow Into Correction
Profile
Emcure Pharmaceuticals Limited is an Indian multinational pharmaceutical company, headquartered in Pune. Emcure's product portfolio includes tablets, capsules and injectables. The company produces gynaecology, cardiovascular, oncology and blood therapeutic drugs, HIV antivirals and other anti-infectives, and vitamins and minerals. Wikipedia
Tungkol sa Emcure Pharmaceuticals Ltd
CEOSatish Ramanlal Mehta
Mga Empleyado6.91K
ItinatagAbr 16, 1981
Headquarters-
SektorHealth Care
Industriya-
Websiteemcure.com